All news articles for October 2020

© GettyImages/solarseven

Cobra to supply plasmids to UK COVID-19 vaccine developer

By Jane Byrne

Contract development and manufacturing organization (CDMO), Cobra Biologics, has been selected to manufacture plasmids for a Phase I clinical trial of a COVID-19 vaccine being developed by UK company, Scancell.

Pic:getty/dilenua

Sartorius acquires BIA Separations for $423m

By Rachel Arthur

German life science company Sartorius will merge Slovenian purification specialist BIA Separations with Sartorius Stedim Biotech, in a deal worth €360m ($423m).

Follow us

Products

View more

Webinars